retatrutide phase 3 trial results Updates: Significant Weight Loss and Improved Complications | Ahmad Bahareth, MD posted on the topic Lilly's triple agonist achieves 16.8%

Diabetes 62 , 30443052 (2013)

MT-1 5mg is a synthetic linear analog of -melanocyte-stimulating hormone (-MSH) commonly used as an experimental peptide in laboratory investigations of melanogenesis, photoprotection, and melanocortin-1 receptor (MC1R) signaling

This sounds revolutionary, but it has received a mixed reception among clinicians, with many citing concerns that once-monthly dosing may paradoxically worsen patient compliance (patients may simply forget to take the medication, as once-monthly administration may not be frequent enough to build adherence behaviours) and slow dose titration

The blue color comes from copper ions, and excessive copper exposure could potentially cause irritation or other issues

Available online at: March 17, 2025)